Results for ''
People with longstanding kidney disease face health issues like heart disease and diabetes that could impact their risk of severe COVID-19 and life expectancy, according to a new study enabled by...
Obesity dramatically increases the risk of death from COVID-19 but, the extent of this risk across different body weights and ethnic groups was not clear. Researchers using health and Census...
People with severe mental illness have a lower life expectancy and a higher risk of physical conditions. To improve how these comorbidities can be detected and predicted, researchers have used...
Diabetes is not only a major health problem in itself, but it also increases the risk of cardiovascular and kidney disease. Researchers have used national healthcare records to identify the...
The current standard measure of glucose control is not useful for measuring short-term changes and can struggle to work in people with some blood conditions. Researchers supported by HDR UK used a...
A large-scale clinical trial of a monoclonal antibody treatment for COVID-19 showed that it could reduce deaths by 21 per cent in people who had not mounted a natural antibody response of their own.
Study published in The Lancet Digital Health and supported by the BHF Data Science Centre used health data from 57 million people in England to build the most complete picture of the pandemic in a...
Our Open Access Publication of the Month, May: Selected by the Impact Committee for its research excellence
We explore how routinely collected health data may hold the key to super-charging how clinical trials are delivered, and in turn, how quickly we can bring improvements to people's lives.
